Skip to main content
. 2021 May 11;21:157. doi: 10.1186/s12890-021-01517-3

Table 1.

Patients with and without delirium

Variables No delirium
N = 887
Delirium
N = 196
p
Age, years 69 (61–77) 78 (71–84)  < 0.01
Female/male 261/626 49/147 0.22
APACHE II score 14 (12–17) 17 (14–20)  < 0.01
Reasons for NIV
 COPD exacerbation 477 (53.8%) 107 (54.6%) 0.67
 Pneumonia 184 (20.7%) 48 (24.5%)
 ARDS 63 (7.1%) 11 (5.6%)
 Pulmonary cancer 49 (5.5%) 11 (5.6%)
 Interstitial lung disease 22 (2.5%) 6 (3.1%)
 Asthma 14 (1.6%) 1 (0.5%)
 Heart failure 10 (1.1%) 2 (1.0%)
 OHS 11 (1.2%) 2 (1.0%)
 Pulmonary embolism 15 (1.7%) 0 (0%)
 Others 42 (4.7%) 8 (4.1%)
Underlying disease
 Hypertension 335 (37.8%) 86 (43.9%) 0.12
 Diabetes mellitus 180 (20.3%) 51 (26.0%) 0.08
 Chronic heart disease 163 (18.4%) 47 (24.0%) 0.09
 Chronic liver disease 36 (4.1%) 4 (2.0%) 0.21
 Chronic kidney disease 30 (3.4%) 11 (5.6%) 0.15
Variables collected before NIV
 GCS 15 (15–15) 15 (14–15)  < 0.01
 HR, beats/min 111 ± 23 112 ± 22 0.92
 RR, breaths/min 30 (26–35) 30 (26–35) 0.75
 MAP, mmHg 98 (87–111) 92 (83–106)  < 0.01
 pH 7.37 (7.29–7.45) 7.34 (7.26–7.44)  < 0.01
 PaCO2, mmHg 57 (35–77) 58 (37–81) 0.20
 PaO2/FiO2, mmHg 167 (127–224) 168 (126–243) 0.71
Outcomes
 NIV failure 186 (21.0%) 74 (37.8%)  < 0.01
 NIV duration, days 3.7 (1.7–5.9) 6.3 (2.7–11.0)  < 0.01
 ICU LOS, days 6.0 (3.8–9.2) 9.0 (4.8–15.2)  < 0.01
 Hospital LOS, days 11.0 (6.8–17.0) 14.5 (7.1–21.1)  < 0.01
 ICU mortality 127 (14.3%) 65 (33.2%)  < 0.01
 Hospital mortality 151 (17.0%) 73 (37.2%)  < 0.01

NIV noninvasive ventilation, COPD chronic obstructive pulmonary disease, ARDS acute respiratory disease syndrome, OHS obesity hypoventilation syndrome, GCS Glasgow coma scale, HR heart rate, RR respiratory rate, MAP mean arterial pressure, LOS length of stay